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Abstract Although most cases of primary progressive
aphasia (PPA) have one of the varieties of frontotemporal
lobar degeneration (FTLD) as their pathological substrate, a
subset shows Alzheimer’s disease (AD) pathology. We
report that all eight cases in our clinic diagnosed as possible
PPA, on account of the presence of episodic memory diY-
culties in addition to severe language impairment at the
onset of disease, showed AD pathology. Neither focal
accentuation of AD pathology nor vascular lesions in lan-
guage-related areas was observed. Seven of these eight
patients showed large argyrophilic thorny astrocyte clusters
(ATAC) in the fronto-temporo-parietal cortex and subcorti-
cal white matter. The intensely tau immunoreactive astro-
cytes in ATAC were morphologically similar to the
perivascular, subpial, and subependymal astrocytes in eld-
erly brains, but ATAC diVer from the latter by the cortical
and subcortical location, widespread distribution outside
the medial temporal lobe, and intense argyrophilia. The
location of ATAC was related to neither local variations in
the load of AD pathology, nor the myelin density of white
matter. ATAC were not seen in a comparison group of six
cases of AD without a prominent aphasia syndrome.
Because of the similarity of astrocytes in ATAC to those
seen independently of AD pathology in several subtypes of
FTLD and two reported cases of PPA we hypothesize that
they are a marker of a pathological process concurrent with
AD, and related to the focality of the clinical presentation.
Keywords Tau · Frontotemporal dementia · FTLD · 
Neurodegeneration · Cerebral cortex · Gallyas
Introduction
Although described in the original papers of Arnold Pick
and other early reports of similar conditions, the recogni-
tion of primary progressive aphasia (PPA) as a relatively
common syndrome followed the seminal work of Marsel
Mesulam [45]. He deWned PPA as a gradual isolated disso-
lution of language, contrasting with the preservation of
other cognitive functions and behavior [46]. The structural
basis of PPA has remained controversial [33].
Neuropathological examination of autopsied cases or of
brain biopsies have shown that PPA is most commonly
associated with diVerent forms of frontotemporal lobar
degeneration (FTLD) [5], including FTLD with Pick bodies
[14, 20, 31, 66], corticobasal degeneration (CBD) [9, 22,
39], FTLD with motor neuron disease-type inclusions or
ubiquitin-only inclusions (FTLD-U) [34, 60], and dementia
lacking distinctive histopathology [7, 15, 35, 44, 57, 59,
61], although the latter diagnosis, always questionable, can-
not even be considered in the absence of ubiquitin immuno-
stains.
On the other hand, a number of reported cases of PPA have
shown as the only recognized pathology neuroWbrillary
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diagnosis of Alzheimer’s disease (AD) by current criteria.
As many as one third of patients diagnosed clinically as
either progressive non-Xuent aphasia (PNFA) or semantic
dementia showed this pattern [36]. Some reports have
remarked the relative sparing of medial temporal lobe
structures (hippocampus and entorhinal cortex) [16, 17,
56]. Galton et al. [10] have reported a large series of atypi-
cal presentations of pathologically conWrmed AD, which
included six cases of PPA. Non-Xuent, mixed, and Xuent
aphasia were represented. Although episodic memory deW-
cits were present in most patients, there were exceptions.
Thus, neither a clinical proWle of patients with PPA and AD
pathology, nor a pathological diVerence between cases with
AD pathology with and without PPA symptoms has been
reported.
We Wrst encountered an opportunity to make a contri-
bution to the questions above when we classiWed 13
patients with PPA into a probable and a possible group,
depending on whether non-language memory deWcits
were present or absent at onset. All ten patients with deW-
nite PPA showed FTLD pathology (3 FTLD with Pick
bodies, 4 CBD, 3 FTLD-U). In contrast all three patients
with memory deWcits showed AD pathology [52]. How-
ever, there was a surprising lack of correspondence
between the widespread AD pathology and the localized
clinical manifestation. Later, two of us (DM and JW)
observed a distinctive type of glial abnormality in the
brains of these patients, and we investigated the presence
and distribution of this lesion in all available brains with a
reliable diagnosis of possible PPA and a group of AD
patients without possible PPA.
Patients and methods
Among the patients examined by one of us (AK) at the
Cognitive Neurology Clinic of the University of Western
Ontario, 20 who presented with PPA came to autopsy prior
to the end of 2002, and the brains were examined by one of
the authors. 12 of these received a diagnosis of probable
PPA, when aphasia, whether anomic, logopenic, or non-
Xuent was the only initial symptom. The pathological diag-
nosis was one of the varieties of FTLD: FTLD with Pick
bodies, CBD, or FTLD-U [32, 53]. Eight patients received
a diagnosis of possible PPA because the initial history was
considered to have a component of memory impairment
accompanying language deWcits: they are the subject of the
present report. All patients were assessed with the Western
Aphasia Battery (WAB) [29]. Other tests used included the
mini mental state examination (MMSE), and Mattis demen-
tia rating scale (DRS). The frontal behavioral inventory
(FBI) was obtained with the main caregiver.
For comparison, we used six patients with a clinical
diagnosis of probable Alzheimer’s disease by NINCDS cri-
teria [42] in whom review of the clinical history did not
reveal any suggestion of PPA, and who received a patho-
logical diagnosis of Alzheimer disease by CERAD criteria
[47].
Brains removed at autopsy were weighed, Wxed in for-
malin for 1–2 weeks, and coronally sectioned. Standard
blocks were embedded in paraYn, and 8 m sections
stained using the H&E, Luxol Fast Blue, Bielschowsky,
and Gallyas techniques [50]. Immunostains were performed
on 4 m sections by the avidin–biotin–peroxidase method,
using Vector Elite kit and diaminobenzidine (DAB) as pre-
viously described [40]. Appropriate positive and negative
controls were used in all cases. For detecting pathological
tau proteins we used two mouse monoclonal antibodies,
one conformation-dependent, tau-2 (Sigma, 1:200),
directed against Ala95 through Ala108 of bovine tau, and
speciWcally for the Ser conformation of the amino-terminal
portion of human tau [65], and one phosphorylation-
dependent, AT8 (Pierce Endogen, 1:100), that recognizes
tau protein phosphorylated at both ser 202 and thr 205, [12]
(Innogenetics, Ghent, Belgium). Other antibodies used
include anti GFAP (Dako, 1:500), anti ubiquitin (Dako,
1:50), anti -synuclein (Zymed, 1:50), and anti Chromogra-
nin A (Dako, 1:2,000). Double labeling was carried out by
the sequential method, using a brown chromagen (DAB)
for the monoclonal tau antibodies and a purple chromagen
(VIP substrate, Vector laboratories) for GFAP. Runs omit-
ting each primary antibody were used as controls.
In the initial evaluation all the clinical information was
available to the pathologists. In order to conWrm the consis-
tency of the Wnding reported here ten slides showing argyr-
ophilic thorny astrocyte clusters (ATAC) and ten slides
from corresponding areas in the AD controls were masked
and given in random order to one of the pathologist (DM)




The common feature of the history was the salience of lan-
guage impairment in contrast to the relative preservation of
activities of daily living, navigation, calculation, and plan-
ning, even if episodic memory was deWnitely involved from
the outset. For example, a 75-year-old woman was able to
drive her car around town without diYculty, depositing or
withdrawing money from the bank, maintaining her house,
cooking and baking at a time when her language was
reduced to garbled speech. The onset was insidious and123
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were attentive and cooperative. Word Wnding diYculty was
more apparent on connected speech than on naming. Fre-
quent paraphasias included mostly word substitutions.
Impairment of both comprehension and repetition initially
involved complex sentences and eventually short ones as
well. The following written response to a question about
the weather demonstrates the same severe semantic jargon
and paragrammatism found in spontaneous speech: “They
must dry sometimes wet in (town) in snow after in the
monthly”. Spontaneous speech Xuency varied among
patients, depending on the stage they were examined, but
characteristically Xuency was preserved late into the illness
in contrast to PNFA. Constructional apraxia was common,
but limb apraxia was not a feature. Preservation of motor
skills was exempliWed in patients taking long bicycle rides.
Many patients developed behavioral symptoms. Some of
these such as the mirror and Capgras delusion are in our
experience more characteristic of Alzheimer’s than Fronto-
temporal Disease (mirror = confusion of a mirror image as
a stranger, Capgras = delusion of a close relative as an
impostor). The FBI scores averaged 18 (below frontotem-
poral dementia cutoV, but compatible with PPA or AD).
Eventually patients progressed to a severe global demen-
tia and some to mutism. The clinical features of the eight
patients are summarized in Table 1. The WAB scores (for
quantization of language features) in the table are from the
initial examination. The pattern suggested Xuent aphasia
ranging from anomia to Wernicke’s aphasia, more charac-
teristic of AD than PPA [1, 30]. Other cognitive test aver-
ages/possible maximum: MMSE 8.5/30, DRS 72.8/144 are
compatible with other PPA or severe AD patients. The
impaired language skills are the likely cause of the low
MMSE scores.
Structural brain imaging with CT or MRI showed
mild diVuse atrophy in four patients and focal atrophy
accompanied by distinct asymmetry in the other four
(Fig. 1). In most cases HMPAO-SPECT showed parietal
hypoperfusion.
Pathology
Gross exam of the brain in all cases showed diVuse, moder-
ately severe cortical atrophy lacking any obvious lobar
accentuation, but often with perisylvian predominance
(Fig. 2a), and on serial sections ventricular dilatation and
severe hippocampal atrophy (Fig. 2b). In only one case was
the atrophy considered grossly asymmetrical, left predomi-
nant. On microscopic examination using either Gallyas
(Fig. 3a) or tau immunostains (Fig. 3b), all cases showed
suYcient neuroWbrillary tangles and neuritic plaques to be
assigned to the “high likelihood that the dementia was due
































































































































































































































































































































































































































































































































































































































































































































































































350 Acta Neuropathol (2007) 114:347–357regional distribution of lesions was consistent with Braak
stages 5–6. In one case, a woman aged 70 at the time of
death (patient #8), no additional histological abnormalities
were present, other than those expected in AD, such as
amyloid angiopathy. The other seven cases showed on tau
immunostains (Fig. 4) and Gallyas stains (Fig. 5) large
Fig. 1 Magnetic resonance im-
ages of patients at presentation. 
a Patient 7, 74-year-old female, 
T1 weighted image, showing 
distinctly asymmetric atrophy 
preferentially involving the left 
cerebral hemisphere. b Patient 1, 
75-year-old male, T2 weighted 
image, demonstrating atrophy 
primarily aVecting the left 
Sylvian region
Fig. 2 Gross pathology. a Patient 3, 74-year-old male. DiVuse cortical
atrophy lacking any obvious lobar pattern, but with perisylvian accen-
tuation. b Coronal sections demonstrating cortical and hippocampal
atrophy with no obvious asymmetry
Fig. 3 Alzheimer pathology. The middle frontal gyrus shows neuroW-
brillary tangles (black arrow) and neuritic plaques (white arrow), uti-
lizing the Gallyas silver stain (a) or tau (AT8) immunostains (b). Two
neuroWbrillary tangle-bearing neurons are enlarged in the insets. Cali-
bration bars a 200 m, b 50 m123
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white matter, made up of argyrophilic thorny astrocytes
(ATA). We have named these structures ATAC (Figs. 4a,
5a). ATA had an eccentric nucleus and plump perikarya
with a thorny outline, the latter labeled by both tau-2 and
AT8 tau antibodies in a patchy pattern of coarse dense
strands or clumps, usually on lighter stained background
(Fig. 4b). Also stained were a variable proportion of ATA’s
long varicose processes, often showing sucking feet on
reaching the wall of blood vessels (Fig. 4c). ATA did not
send processes to neighboring neuritic plaques (Fig. 4d, e).
Tau-2 ATA staining was distinctly less intense than neuro-
Wbrillary tangles (Fig. 4f), but this was not obvious on AT8
staining. The Gallyas technique detected the same number
of clusters and of astrocytes in the clusters as the tau immu-
nostains (Fig. 5a). It stained either the entire perikaryon
(Fig. 5b) or only some strands (Fig. 5c). The astrocytic
nature of the argyrophilic cells was supported by the forma-
tion of vascular end-feet (Fig. 5d). When in the cortex ATA
were not topographically related to tangle-bearing neurons
(Fig. 5e). ATA were not stained by the Bielschowsky tech-
nique. Double labeling experiments with GFAP and tau
(both tau-2 and AT8) showed some cells intensely express-
ing both markers, but in most tau-expressing cells GFAP
staining is limited to bundles at the perikaryal periphery
and the processes (Fig. 6). Astrocyte morphology and areal
density was similar regardless of tau expression, and weak
or intense GFAP labeling. No immunoreactivity to either
ubiquitin or -synuclein was found in ATAC.
The clusters as a whole (ATAC) had a compact oval
shape and measured from a few hundred micrometers to
5–10 mm in diameter. When located in the subcortical white
Fig. 4 Argyrophilic thorny astrocyte clusters (ATAC) demonstrated
with tau immunostains. a A large ATAC (white asterisk at its center) is
present and the subcortical white matter near the grey–white junction.
Some extensions form collars around blood vessels (black arrow). Infe-
rior frontal cortex, AT8 immunostain. Bar 1 mm. b The cells in ATAC
show a diVuse staining of patchy intensity of stout perikarya with a
thorny outline (two labeled with black arrows). Tau-2 immunostain.
Bar 20 m. c The perivascular collars (asterisk on vessel) are formed by
astrocytic processes and their end-feet. AT8 immunostain. Bar 20 m.
d Unlike the neighboring vessel (white arrow), neuritic plaques in the
cortex (black arrow) are not associated with astrocytic process, even if
immunolabeled astrocytes (red arrow) are present in the neighborhood.
Tau-2 immunostain. Bar 100 m. e Higher magniWcation of d, slightly
rotated. The same plaque, with its tau positive neurites, is arrowed. Bar
20 m. f Thorny astrocytes (black arrow) are less intensely stained by
tau-2 than neuroWbrillary tangles (red arrow). Bar 20 m123
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(Fig. 4a). Blood vessels within an ATAC were surrounded
by a halo of argyrophilic, tau immunoreactive processes,
but ATAC showed no relationship to subpial or subependy-
mal collections of thorn-shaped astrocytes. White matter
areas containing ATAC demonstrated no discernible
change on myelin stains, and ATAC could not be delineated
on GFAP immunostains in the cortex. ATAC showed no
consistent topographic correlation with the density of amy-
loid deposits or neuroWbrillary tangles.
The areas involved were the white and grey matter of the
temporal lobe, including the gyrus ambiens, parahippocam-
pal gyrus, fusiform gyrus, inferior, middle, and superior
temporal gyri, the frontal dorsolateral and orbitofrontal cor-
tices, the cingulate gyri and occasionally the inferior parie-
tal lobule. They were not found in the insula, occipital lobe,
hippocampus, amygdala, thalamus, basal ganglia, brain-
stem, or cerebellum. There were no obvious focal accentua-
tions of the severity of AD pathology, or diVerences
between right and left cerebral hemispheres. Neither tufted
astrocytes nor glial plaques were seen. Additional neurode-
generative features were the presence of argyrophilic grains
and in the parahippocampal gyrus ballooned neurons in a
83-year-old female (patient #6), and of neuroWbrillary tan-
gles in the substantia nigra and periaqueductal grey matter
of a 74-year-old male (patient #3). Severe subicular atrophy
with relative sparing of the hippocampus was observed in
patients #3 and #6. No infarcts were identiWed on gross
examination in any patients, but microscopic infarcts (less
than 0.5 mm in diameter) were observed in the cortex of
patients #1 and #5, and in the left thalamus of patient #5.
The group of patients showing ATAC consisted of four
men and three women. The average age at onset for men
and women was 67.5 and 69.7 years, and at death 76.3 and
79.7, resulting in an average duration until death of 8.8 and
10 years, respectively. Brain weight averaged 1,145 g for
men, and 1,008 g in women.
None of the six cases of AD without PPA used as the
comparison group showed ATAC (Fig. 7).
Discussion
Although the literature does not describe this association,
Wnding AD pathology as the pathological substrate of pos-
sible PPA is not surprising, providing a known basis for the
memory impairment accompanying the aphasia. Recently,
subtypes of PPA have been identiWed on clinical, imaging,
and genetic bases: PNFA, semantic dementia, and logope-
nic progressive aphasia. The latter is characterized by ano-
mia, slow speech, and impaired syntactic comprehension
clinically, and left posterior temporal cortex and inferior
parietal lobule atrophy on imaging. In contrast to the two
other forms of PPA, there is over-representation of the
ApoE 4 allele, as high as 67%, suggesting a link to AD
[13]. The relationship of this form to pathologically identi-
Wed AD remains to be seen. In the present series the clinical
characteristics in the Wrst assessment were closer to the
Xuent aphasia seen in Alzheimer’s disease than the nonXu-
ent aphasia associated with FTLD. Many patients at early
Fig. 5 Argyrophilic thorny astrocyte clusters demonstrated with the
Gallyas stain. a Two ATAC (arrows) in the subcortical white matter,
frontal lobe. Bar 200 m. b A thorny astrocyte with diVuse perikaryal
staining, albeit of patchy intensity. Bar 10 m. c Staining is limited to
strands in the perikarya of these two thorny astrocytes. Bar 10 m.
d The processes of some thorny astrocytes (arrow) form end-feet on
blood vessels. Bar 10 m. e Thorny astrocytes in the cortex in the
vicinity of a neuron (arrow) lacking neuroWbrillary pathology. Bar
10 m123
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tinguishing feature is the episodic memory loss in possible
PPA. Semantic dementia patients remain Xuent but main-
tain episodic memory while loosing semantic memory and
comprehension. The speech at the last assessment was non-
Xuent in four patients with ATAC and still Xuent in the
patient without ATAC. Aphasia was more prominent in all
the possible PPA patients than those diagnosed as AD clin-
ically.
The focal accentuation of the atrophy and asymmetry
observed in imaging in half of the cases at presentation was
much less prevalent at the time of autopsy, once the disease
had run its course, a pattern commonly seen in FTLD.
Interestingly, the patient without ATAC also showed left
predominant atrophy.
Our second Wnding concerns the presence of ATAC in
the majority of possible PPA cases. The constituent thorny
astrocytes are a subtype of glial Wbrillary tangles (GFT),
argyrophilic masses containing deposits of abnormal tau
proteins located in the cytoplasm of glial cells [37]. Elec-
tron microscopy typically shows bundles of 15 nm straight
tubules [22]. All forms lack tau isoforms corresponding to
the expression of alternatively spliced exons 2 and 3 [55],
but otherwise are labeled with all tau antibodies. In contrast
to neuroWbrillary tangles, GFT are poorly labeled by anti-
bodies to ubiquitin, and not at all by antibodies to apolipo-
protein E, alpha-1-antichymotrypsin, and heparan sulfate
[22]. Oligodendrocytes present a single form, named coiled
Fig. 6 Double labeling for 
GFAP (purple, black arrows) 
and tau-2 (brown, red arrows). 
a Most astrocytes within a 
cluster predominantly express 
either GFAP or tau. Bar 40 m. 
b–d Co-expression of GFAP and 
tau is visible in a subset of astro-
cytes. GFAP may be condensed 
in bundles at the periphery of the 
perikaryon (b), in the processes 
(c), or occupy much of the core 
of the cell body (d). Bar 10 m. 
e The morphology of processes 
forming vascular end-feet is 
similar in astrocytes chieXy 
expressing either tau or GFAP. 
Bar 20 m. f–g Controls. After 
omitting the primary antibody 
for tau, only purple GFAP 
stained astrocytes are seen (f), 
whereas omitting the GFAP pri-
mary results in brown only stain-
ing for tau (g). Bars f 40 m, 
g 20 m
Fig. 7 Alzheimer’s disease patient without aphasia. This section,
including the depth of the collateral sulcus (top left) and the CA1 sector
of the hippocampus immunostained with AT8, shows abundant
plaques and tangles, but complete absence of subpial, subependymal,
or white matter tau deposits in astrocytes. Bar 1 mm123
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the white matter [4], whereas at least three varieties can be
identiWed in astrocytes. Two of these appear in protoplas-
mic astrocytes, identiWed by their CD44 positive, GFAP
negative immunohistochemical proWles, are predominantly
located in the cerebral cortex and subcortical grey masses
rather than the white matter, and involve the processes
rather than the cell body. Tufted astrocytes are character-
ized by Wne process radiating from the inconspicuous cell
body, whereas glial plaques consist of a crown of processes
devoid of an obvious connection to a cell body. The other
variety, named thorny astrocytes or thorn-shaped astro-
cytes, show a conspicuous GFAP positive cytoplasm drawn
into funnel-shaped thick process, reaching as end feet peri-
vascular subpial and subependymal linings [69].
In terms of the signiWcance of GFT, coiled bodies are
present in many taupathies, including dementia with argyr-
ophilic grains [4, 25, 41], PSP [68], CBD [63], and sub-
acute sclerosing panencephalitis [24]. Tufted astrocytes are
considered pathognomonic of PSP [19, 67], and glial
plaques are characteristic of CBD [8, 37, 38, 2],
The nosological signiWcance of thorny astrocytes is less
clear. Although initially described in small numbers in a
limited area in patients with several diseases characterized
by neuronal tau deposits [26], tau + thorny astrocytes in
subpial and subependymal regions are common in the
medial temporal lobe of elderly subjects, albiet only a small
subset demonstrate argyrophilia. There is no correlation
between the abundance of thorny astrocytes and neuroW-
brillary tangle stage, amyloid deposition, or argyrophilic
grain disease severity. The presence of ApoE 4 allele is not
associated with the presence of thorny astrocytes [58]. On
the other hand, abundant ATAs have been restricted to
postencephalitic parkinsonism of von-Economo type [23]
and three forms of frontotemporal degeneration, FTLD
with Pick bodies, PSP, and diVuse neuroWbrillary tangles
with calciWcation. In FTLD with Pick bodies they were
described in the subcortical white matter of atrophic middle
and inferior temporal gyri [70], or in aVected cortical areas
[28, 71]. In PSP thorny astrocytes appear in areas with rela-
tively minor neuronal loss including the striatum, thalamus,
superior colliculus and frontal and motor cortex, but not in
the white matter [54, 69]. In dementia with diVuse neuroW-
brillary tangles with calciWcation, which can be considered
a subset of neuroWbrillary tangle dementia [43], thorny
astrocytes form subcortical and cortical clusters, similar to
our ATAC [18]. However the stated coincidence of the dis-
tribution of thorn-shaped astrocytes and gliosis [18] is at
odds with our observations on ATAC.
Finally, two cases of PPA in which astrocytic tau depos-
its constituted the dominant pathology have been reported.
The patient described by Molina et al. [49] was an 80-year-
old woman with PPA who in a left temporal lobe biopsy
showed astrocytes stained by Gallyas and containing tau
and ubiquitin positive inclusions located in cortex and
white matter, predominantly at the grey–white junction, as
in our cases. In addition, coiled bodies were present. There
was no hint of Alzheimer disease, nor were any tau deposits
found in neurons other than rare diVuse perikaryal staining.
Ballooned neurons and superWcial spongiosis were not
present. The second case, reported by Wakabayashi et al.
[64] in a 72-year-old man with a 6-year typical aphemic
history, showed tufted astrocytes in layers II–V in the lower
third of the left primary motor area, and to a lesser degree
in perirolandic cortex bilaterally. The astrocytic inclusions
were stained by phosphorylation dependent (AT8) and
independent (tau-2) antibodies, but not by antibodies to
alpha synuclein, or ubiquitin. There were numerous oligo-
dendroglial inclusions (coiled bodies) with the same immu-
noreactive pattern in deep cortical layers and white matter.
SuperWcial linear spongiosis was observed in the aVected
regions. Western blot analysis of insoluble tau proteins
after dephosphorylation was reported as demonstrating
three major bands corresponding to 4R and 3R isoforms,
with a preponderance of 4R. Other Wndings included argyr-
ophilic grains and a few neuroWbrillary tangles in the hip-
pocampus, but no neuroWbrillary tangles in cortical or
subcortical neurons. Thus, the authors did not consider that
the patient’s disease could be classiWed as PSP, even if the
astrocytic inclusions were similar to those seen in this dis-
ease [64]. Abundant cortical tufted astrocytes are a charac-
teristic feature in PSP cases presenting with PNFA [3, 27,
48].
It should be mentioned that mutations in exons 1 and 10
and the intron following exon 10 of the gene MAPT are
associated with robust astrocytic and oligodendroglial, in
addition to neuronal, tau deposition [11].
Argyrophilic thorny astrocyte cluster represents a lesion
not fully characterized in the literature. The basic process of
deposition of tau in GFAP immunoreactive Wbrous astro-
cytes is one shared with aging, but in contrast to the peri-
ventricular, subependymal, and subpial location of the
thorny astrocytes described in normal aged subjects [58],
ATAC are located in the cerebral cortex and subcortical
white matter, are not restricted to the medial temporal lobe
but involve the frontal, temporal, and parietal lobes, and
display intense argyrophilia. Similar points of distinction in
relation to normal aging were advanced in the report of the
clusters of GFTs associated with diVuse neuroWbrillary tan-
gles with calciWcation [18], lesions closely related to
ATAC. More research will be necessary to establish
whether ATAC represent an intensiWcation of the astrocytic
changes seen in aging, or else a diVerent phenomenon, pos-
sibly related to FTLD pathologies [51] This distinction is
well known in neuronal tau deposits, where neuroWbrillary
tangles in AD replicate the biochemical composition and123
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brains, whereas neuroWbrillary tangles in CBD or progres-
sive supranuclear palsy do neither [6]. Other issue for
future research is the range of conditions in which ATAC
appear. Our preliminary observations indicate that ATAC
are not found in FTLD-U with either PPA or behavioral
presentations.
We hypothesize that ATAC represent a marker of a pro-
cess, co-exiting but probably independent of AD, and
responsible for the prominent focal clinical manifestations.
The argument for the independence of ATAC and AD is
grounded on cases in which subcortical thorny astrocytes
are either the only reported pathology [49] or accompany
FTLD with Pick bodies rather than AD [70]. In addition,
the brains reported here showed no topographic relation-
ship between the severity of plaques and tangles on the one
hand and ATAC on the other. ATAC could be the result of
pathogenetic processes related to those subjacent to FTLD.
Alternatively, they could be secondary to alterations in the
blood-brain barrier, a possibility raised in relation to the
thorny astrocytes of normal aged brains [58], and compati-
ble with ATAC’s patchy, nonsystematic distribution.
Although our Wndings are consistent with either hypothesis,
it should be noted that a related lesion, tufted astrocytes in
PSP, are considered a degenerative rather than reactive pro-
cess because their distribution is unrelated to reactive astro-
cytes in the vicinity of infarcts or neuroWbrillary tangles
[62]. The consistent development in aged baboons, but not
other primate species, of tau + thorny astrocytes in a stereo-
typed distribution suggests that genetic variations contrib-
ute to the formation of ATAC. An important focus for
future research is the relationship between the marker
(ATAC) and the clinical manifestation (aphasia).
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